Intuitive Surgical EPS Estimate Rises 14.9% as Forward P/E Hits 49.3x
Intuitive Surgical’s shares fell 1.32% while outperforming the S&P 500’s 1.33% decline and have gained 4.28% over the past month versus a 0.66% Medical sector drop. Analysts forecast Q1 EPS of $2.08 (+14.9%) on $2.61B revenue (+15.9%), yielding a 49.3x forward P/E.
1. Recent Stock Performance
Shares of Intuitive Surgical dropped 1.32% in the latest session while outperforming the S&P 500’s 1.33% decline. Over the past month, the stock has risen 4.28% compared to a 0.66% loss in the Medical sector.
2. Upcoming Earnings Projections
Analysts forecast first-quarter EPS of $2.08, representing a 14.92% year-over-year increase, on revenue estimated at $2.61 billion, up 15.86% from the prior year. Annual consensus projects $10.07 in EPS and $11.56 billion in revenue.
3. Valuation Metrics
The company trades at a 49.34x forward P/E ratio, a premium to the Medical Instruments industry average of 21.04x. Its PEG ratio stands at 3.14 versus the industry’s 2.17, reflecting higher expected growth baked into current valuation.
4. Zacks Rank and Industry Position
Intuitive Surgical holds a Zacks Rank of #1 (Strong Buy), driven by positive estimate revisions, with the Medical Instruments industry ranked in the top 34% of over 250 industries. This top-tier position underscores strong near-term optimism.